ERFSF (Eurofins Scientific SE) EBITDA per Share: $9.56 (TTM As of Dec. 2025)


ERFSF Eurofins Scientific SE ERFSF
77 GF Score
Price $79.77
GF Value $77.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE EBITDA per Share?

Eurofins Scientific SE ERFSF +3.01% 77 EBITDA per Share is $9.56 as of Dec. 2025. GuruFocus rates ERFSF with a GF Score™ of 77/100 and a GF Value™ of $77.44 (Fairly Valued). The stock has 7 warning signs investors should review. Among 170 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks worse than 61.18% on this metric.

Eurofins Scientific SE's EBITDA per Share for the six months ended in Dec. 2025 was $4.83. Its EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $9.56.

During the past 12 months, the average EBITDA per Share Growth Rate of Eurofins Scientific SE was 14.60% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 3.10% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 0.80% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Eurofins Scientific SE's EBITDA per Share or its related term are showing as below:

ERFSF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -5.3   Med: 23.3   Max: 41.6
Current: 3.1

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Eurofins Scientific SE was 41.60% per year. The lowest was -5.30% per year. And the median was 23.30% per year.

ERFSF's 3-Year EBITDA Growth Rate is ranked worse than
61.18% of 170 companies
in the Medical Diagnostics & Research industry
Industry Median: 10.8 vs ERFSF: 3.10

Eurofins Scientific SE's EBITDA for the six months ended in Dec. 2025 was $890 Mil.

During the past 12 months, the average EBITDA Growth Rate of Eurofins Scientific SE was 9.80% per year. During the past 3 years, the average EBITDA Growth Rate was 0.90% per year. During the past 5 years, the average EBITDA Growth Rate was -0.20% per year. During the past 10 years, the average EBITDA Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Eurofins Scientific SE was 46.00% per year. The lowest was -6.20% per year. And the median was 25.90% per year.


Eurofins Scientific SE  (OTCPK:ERFSF) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Eurofins Scientific SE EBITDA per Share Related Terms


Eurofins Scientific SE EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE EBITDA per Share Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.54 7.96 6.71 7.52 9.63

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 3.90 3.73 4.74 4.83
ERFSF
77GF Score
Eurofins Scientific SE ERFSF
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Eurofins Scientific SE's EBITDA per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA per Share(A: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=1796.37/186.500
=9.63

Eurofins Scientific SE's EBITDA per Share for the quarter that ended in Dec. 2025 is calculated as

EBITDA per Share(Q: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=890.164/184.500
=4.82

EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $9.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $9.56 mean?
Eurofins Scientific SE (ERFSF) has a EBITDA per Share of $9.56 as of Dec. 2025. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Eurofins Scientific SE and its competitors. According to the industry distribution chart, Eurofins Scientific SE ranks #104 out of 170 companies in the Medical Diagnostics & Research industry, placing it in the top 61.2%.
Is Eurofins Scientific SE's EBITDA per Share too high?
Eurofins Scientific SE's current EBITDA per Share is $9.56. The Medical Diagnostics & Research industry median EBITDA per Share is 10.80. Eurofins Scientific SE's value of $9.56 is 11.5% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #104 out of 170 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's EBITDA per Share compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #104 out of 170 companies for EBITDA per Share. This places Eurofins Scientific SE in the lower half of its industry. The industry median EBITDA per Share is 10.80. Eurofins Scientific SE's value of $9.56 is 11.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Medical Diagnostics & Research company?
The median EBITDA per Share among Medical Diagnostics & Research companies is 10.80, based on 170 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current EBITDA per Share of $9.56 is 11.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA per Share is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current EBITDA per Share is $9.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $77.44, compared to a current price of $79.77 — trading 3% above its estimated fair value. The current EBITDA per Share is $9.56 and 11.5% below the Medical Diagnostics & Research industry median of 10.80. Eurofins Scientific SE's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current EBITDA per Share is $9.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of $79.77 is trading 3% above its estimated GF Value™ of $77.44. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • EBITDA per Share: $9.56
  • GF Value™: $77.44 vs. price of $79.77 (3% above fair value)
  • GF Score™: 77/100 with 7 warning signs
  • Industry Position: 11.5% below the Medical Diagnostics & Research median (#104 of 170)

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
77GF Score

Get the complete analysis for ERFSF

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.77
Price
$77.44
GF Value